bluebird bio

Activity by year

20162017201820192020202120222023202420252026

ContractAcquisition

Dec 20, 2017CONTRACTCarlsbad, California, United States
MilliporeSigma signs viral vector supply agreement with bluebird bio
MilliporeSigma signed a commercial supply agreement to manufacture lentiviral vectors for bluebird bio's gene therapies for rare genetic diseases. The multi-year agreement covers manufacturing at MilliporeSigma's Carlsbad, California facility.
MilliporeSigma bluebird bio customer #Medical Devices prnewswire.com
Nov 29, 2017ACQUISITIONDurham, North Carolina, United States$11.5M
bluebird bio acquires Durham manufacturing facility for $11.5M
bluebird bio acquired a 125,000-square-foot manufacturing facility in Durham, North Carolina, for $11.5 million to produce lentiviral vectors for its cell and gene therapies.
bluebird bio acquirer #Medical Devices genengnews.com
Dec 15, 2016CONTRACTMunich, Germany, Germany
bluebird bio and apceth Biopharma sign commercial manufacturing agreement
bluebird bio and apceth Biopharma entered a strategic manufacturing agreement for European commercial production of bluebird bio's Lenti-D and LentiGlobin gene therapy products at apceth's GMP facility in Munich.
bluebird bio customer apceth Biopharma supplier #Medical Devices biotechnewswire.ai emjreviews.com

Suppliers

Loading…